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BACKGROUND:  Calprotectin  is  a  calcium-binding  and
zinc-binding protein complex that is abundant in the
cytosol of neutrophils. This factor is composed of 8
and 14kDa subunits, which have also been termed
migration  inhibitory  factor-related  proteins  MRP8
and MRP14. We previously reported that rat calpro-
tectin purified from inflammatory neutrophils indu-
ces  apoptosis  of  various  tumor  cells  or  normal
fibroblasts in a zinc-reversible manner.
Aim: The present study was undertaken to elucidate
which  subunit  is  responsible  for  the  apoptosis-
inducing activity, and to explore the mechanism of
zinc-reversible apoptosis induction.
Methods: The apoptosis-inducing activity of recombi-
nant  human  MRP8  (rhMRP8)  and  recombinant
human MRP14 (rhMRP14) was examined against EL-4
lymphoma cells in vitro. To determine whether zinc
deprivation  by  calprotectin  was  essential  for  the
cytotoxicity,  the  activity  of  calprotectin  was  tested
under conditions where physical contact between the
factor and the cells was precluded by a low molecular
weight cut-off dialysis membrane.
Results:  The  cytotoxicity  of  rhMRP14  against  EL-4
cells  was  first  detected  at  10m M  in  a  standard
medium,  whereas  rhMRP8  caused  only  marginal
cytotoxicity  at  40m M.  A  mixture  of  both  proteins
showed higher specific activity (onset of cytotoxicity
at  5m M).  When  the  cells  were cultured  in divalent
cation-depleted medium, each dose–response curve
was shifted to about a four-fold lower concentration
range. Calprotectin  was found to  induce cell  death
even when  the  complex  and  the  target  cells  were
separated by dialysis membrane. A membrane-imper-
meable zinc chelator, diethylenetriamine pentaacetic
acid (DTPA), also induced target cell apoptosis in a
similar  time-course  as  calprotectin.  Moreover,  the
activities of calprotectin and DTPA were completely
inhibited by the presence of zinc ions.
Conclusion: These data indicate that calprotectin has
higher specific activity to induce apoptosis than the
individual subunits, and that the mechanism is exclu-
sion of zinc from target cells.
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Introduction
Neutrophils are known to be inflammatory cells that
secrete  many  protein  factors  including  enzymes,
antibacterial proteins, and cytokines. They play a role
in  controlling  inflammation,  in  addition  to  killing
microorganisms.1,2While searching for the regulatory
activity  within  the  neutrophils,  we  found  that  rat
neutrophils contain a factor having cytostatic activity
against lymphocytes.3This factor is calprotectin.4We
subsequently reported that rat calprotectin has apop-
tosis-inducing activity against various tumor cells5and
normal cell types including fibroblasts.6The apopto-
sis-inducing activity was abrogated by zinc ions, but
not by calcium ions.4–6
Calprotectin is a calcium-binding and zinc-binding
protein  complex  composed  of  8  and  14kDa  pro-
teins.7 These  proteins,  which  belong  to  the  S100
protein  family,8 have  also  been  termed  migration
inhibitory  factor-related  proteins  (MRP)-8  and
MRP14,9 calgranulin  A  and  B,10 or  S100A8  and
S100A9.11 Neutrophils  are  believed  to  be  a  pre-
dominant producer of calprotectin since they contain
a  high  amount  of  the  proteins  in  cytosol.12 The
concentration of  calprotectin in  extracellular  fluids
increases  under  various  inflammatory  condi-
tions,13–17 suggesting  that this factor has important
functions  influencing  inflammatory  processes. The
concentration in normal human serum was reportedly
less  than  1mg/ml,  but  the  titers  increase  in  many
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rheumatoid  arthritis,  or  Crohn’s  disease  (reviewed
elsewhere17). Much intense increase in calprotectin
concentration has been  observed in  body fluids  of
local inflammatory sites than in blood: the concentra-
tion  in  synovial  fluid  of  patients  with  rheumatoid
arthritis was reported to increase sometimes to more
than  100mg/ml.13,15 Very  high  concentrations
(1–20mg/ml)  of  calprotectin  reportedly  existed  in
abscess fluid from human abdominal abscesses.16
Evidence unraveling the extracellular functions of
calprotectin or  its subunit  have been  accumulating
recently. For example, antimicrobial activity18–21 and
regulatory activities towards migration or adherence
of inflammatory cells have been proposed.22,23 The
exact  physiological  roles  of  this  protein  complex,
however, await further investigation.
Our findings concerning the growth-inhibiting and
cell-death-inducing activity suggest  that calprotectin
plays  a  regulatory  role  in  inflammatory  processes
through its effect on the survival and/or growth of
cells involved in the inflammation. It is also suggested
that if a high concentration of calprotectin is present
in the body fluid at locally inflamed sites, this might
cause a delay in tissue repair and have a deleterious
effect on the inflamed tissues. Therefore, discovery of
the mechanism of the apoptosis induction by calpro-
tectin might be important in controlling of inflamma-
tion. The present study was undertaken to determine
whether human calprotectin has apoptosis-inducing
activity,  as  observed  previously  for  the  rat  protein
complexes. The  activities of  the  MRP8  and  MRP14
alone were compared with that of the mixture using
recombinant human MRP8 (rhMRP8) or recombinant
human  MRP14  (rhMRP14).  We  also  explored  the
mechanism of induction of zinc-reversible apoptosis.
The  results  show  that  an  equimolar  mixture  of
rhMRP8  and  rhMRP14  has  higher  specific  activity
than the individual proteins, and suggests that apopto-
sis is induced by exclusion of extracellular zinc ions
by calprotectin from target cells.
Materials and methods
Reagents
Diethylenetriamine  pentaacetic  acid  (DTPA)  and
N,N,N9,N9-tetrakis-(2-pyridylmethyl)ethylenediamine
(TPEN) were purchased from  Sigma  (St  Louis, MO,
USA).  ZnSO4·7H2O  and  other chemicals were  from
Wako Pure Chemical Industries (Osaka, Japan).
Recombinant human MRP8 and recombinant
human MRP14
Recombinant  human  calprotectin  (rhMRP8  and
rhMRP14)  was  prepared  as  described  elsewhere,24
with some modifications. Briefly, competent Escher-
ichia coli strain BL21(DE3) cells (Novagen, Madison,
WI, USA) were transformed by pET1120-MRP8wt or
pET1120MRP14wt  vectors.  The  transformed  cells
were grown in (2 ´ YT) media supplemented with
100mg/ml  of  ampicillin  for  24h,  and  the  cells
produced  the  proteins  as  inclusion  bodies.  The
harvested cells were solubilized with B-PER™ Bacte-
rial Protein Extraction Reagent (Pierce, Rockford, IL,
USA).  The  inclusion  bodies  were  solubilized  with
Inclusion Body Solubilization Reagent (Pierce), and the
proteins  were  refolded  according  to  the  manu-
facturer’s  protocol. The  proteins  were  purified  by
reverse-phase column  chromatography  (Resource™
RPC; Amersham  Pharmacia,  Buckinghamshire,  Eng-
land) furnished in  a BioLogic HR  system (Bio-Rad),
followed by UNO-Q anion exchange chromatography
(Bio-Rad, Hercules, CA, USA). The buffer systems used
were the same as those described previously.24
Cell lines
Mouse EL-4 thymoma cells, human MOLT-4 leukemia
and  MCF-7  mammary  carcinoma  lines  were  main-
tained in RPMI 1640 medium supplemented with 5%
fetal calf serum (FCS). MM46, a transplantable ascites
tumor from a spontaneous mammary carcinoma in a
C3H/He mouse, was passaged weekly in the perito-
neal  cavity  of  male  C3H/He  mice  (Japan  SLC  Inc.,
Shizuoka, Japan).
3-(4,5-Dimetyl-2-thiazolyl)-2,5-diphenyl-2 H-
tetrazolium bromide assay
To evaluate the target cell death, the 3-(4,5-dimethyl-
2-thiazolyl)-2,5-diphenyl-2H-tetrazolium  bromide
(MTT) assay was used.25 EL-4 cells or MM46 cells (1 ´
104 cells/well)  were  cultured  in  96-well  microtest
plates (Iwaki, Chiba, Japan) with 200ml of RPMI 1640
medium (100U of penicillin, 60mg of kanamycin/ml,
supplemented with 5% FCS). The cultures were added
with test samples, and cells were incubated at 37°C in
a humidified atmosphere of 5% CO2 in air. After the
indicated periods, 25ml of MTT (5mg/ml) was added
to  the  cultures,  and  plates  were  incubated  for  an
additional 3h. Then, 150ml of the supernatants was
discarded, 100ml of acidified isopropanol (0.04N HCl
in 2-propanol) was added to each well and the optical
density  (595nm)  was  measured  with  a  microplate
reader  (Multiscan  MS-UV;  Labsystems,  Basingstoke,
UK).
Divalent cation (other than Ca
2+ and
Mg
2+)-depleted medium
To prepare divalent cation-depleted medium, 100ml
of  RPMI-1640  medium  containing 5% FCS that had
been extensively dialyzed against PBS was applied to
a Chelex 100 column (Bio-Rad; 1.0 ´ 20cm). Then,
500mM  CaCl2 and  400mM  MgCl2 were  added  to
supplement calcium and magnesium.
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The requirement of direct contact between rhMRP8/
rhMRP14 complex and EL-4 cells to exert cytotoxic
effects was examined by the double-chamber culture
system. For this, plastic cylinders (15mm in height,
10mm in inner diameter) were used with the edge
on  one  side  sealed  with  dialysis  membrane  (3500
cut-off;  Spectrum  Medical  Ind.,  Los  Angeles,  CA,
USA) as inner chambers. These inner chambers were
set in the wells of 24-well culture plates (Iwaki) at a
location approximately 3mm distant from the dialy-
sis membrane in the inner chamber and the bottom
of  the wells  of  the 24-well  plates (the outer cham-
bers). The  total  culture  volumes  of  the  inner  and
outer  chambers  were  425ml  and  1000ml,  respec-
tively.  Divalent  cation-depleted medium  without  or
with  the  rhMRP8/rhMRP14  complex  (7mM)  was
added to the chambers as indicated, and the double-
chamber system was kept at 4°C for 3 days. There-
after,  EL-4  cells  (2.5 ´ 104 cells and 5 ´ 104 cells)
were  added  to  the  inner  and  outer  chambers,
respectively,  and  the  cells  were  cultured  at  37°C.
After  48h  of  culture,  200ml  aliquots  of  suspended
culture was transferred to 96-well plates to measure
the capacity of MTT reduction of EL-4 cells in each
chamber, using the MTT assay already described.
DNA fragmentation
EL-4 cells were cultured in 12-well  plates (Corning,
Corning, NY, USA) at 3 ´ 106 cells with test samples
for the indicated periods to analyze DNA fragmenta-
tion. After the cells were harvested and washed once
with PBS, 1.5mg DNA extracted with a Genomic DNA
Purification  Kit  (Promega,  Madison, WI,  USA)  was
separated by electrophoresis on 1.5% agarose gel in
TAE buffer (40 mM Tris–HCl, 19 mM acetic acid, and
1 mM  ethylenediamine  tetraacetic  acid)  containing
0.5mg/ml of ethidium bromide.
Results
Cell-death-inducing activity of human
recombinant calprotectin chains
We  previously  reported  that  calprotectin  (MRP8/
MRP14  complex)  derived  from  rat  inflammatory
neutrophils  induces  apoptosis  of  various  tumor
cells4,5,25 and normal fibroblasts,6 and that the apop-
tosis-inducing activity is abrogated by the presence of
zinc.4–6 To  determine  whether  human  calprotectin
shows this cytotoxic activity, and which subunit  of
the protein complex is responsible for the activity, we
compared the cytotoxicity to EL-4 cells of rhMRP8,
rhMRP14 and a mixture of the two, using the MTT
assay.
Figure  1a  shows  that rhMRP14 had more potent
activity than rhMRP8. rhMRP14 inhibited MTT reduc-
tion in EL-4 cells, with an onset at a concentration of
10mM  and  marked  inhibition  at  20mM,  whereas
rhMRP8 showed no inhibition of MTT reduction until
a concentration of 40mM. On the contrary, equimolar
solutions  of  MRP8  and  MRP14  showed  even  more
potent  activity  with  almost  complete  inhibition  at
5mM.  It  was  observed  microscopically  that  the
inhibition of MTT reduction paralleled the emergence
of  apoptotic  bodies  and  apoptotic  cells  having  an
apoptotic appearance, such as condensation or segre-
gation of nuclei.
We previously reported that the effects of calpro-
tectin were shifted to lower concentration ranges in
media depleted of divalent cations other than Ca2+
and Mg2+.6 We next examined whether the specific
activities of rhMRP8, rhMRP14 or their mixture were
also augmented in divalent cation-depleted medium.
Figure  1b  shows  that,  in  fact,  the  dose–response
curves are shifted to about a four-fold lower concen-
tration. A similar observation was made in examining
the  effects  of  calprotectin  on  MM46  mammary
carcinoma cells (data not shown).
Zinc Exclusion and apoptosis by rhMRP8/14
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FIG. 1. Effect of rhMRP8, rhMRP14 or MRP8/MRP14 complex
on the number of EL-4 cells. Cells were cultured with the
indicated concentrations of (j ) rhMRP8, (m ) rhMRP14, or (d )
an equimolar mixture in (a) standard RPMI-1640 medium or
(b) in divalent-cation-depleted medium for 40h. Cell num-
bers were estimated by MTT reduction. Bars represent upper
and lower values of duplicate estimations. When bars are not
shown, they are smaller than the size of the symbols.Lack of required calprotectin binding to the
target cells in cell death induction
Sohnle  and  co-workers suggested  that the  candida-
static activity of calprotectin is caused by exclusion of
zinc from medium.26 Moreover, there is accumulating
evidence that the exclusion  of intracellular zinc by
cell-membrane-permeable  zinc  chelators  such  as
TPEN induces apoptosis of target cells.27–30We were
therefore motivated to investigate whether the exclu-
sion of extracellular zinc by calprotectin causes target
cell  apoptosis. Thus,  although  no  reduction  in  the
number of EL-4 cells grown is found in divalent cation-
depleted medium  (Fig.  1),  the  presence of  even  a
trace amount of zinc supports cell growth.
If extracellular zinc chelation is the mechanism of
apoptosis induction,  it  is possible that direct inter-
action of calprotectin with cells is not required. To
test this hypothesis, we prepared a double-chamber
culture  in  which  inner  and  outer  chambers  were
separated  by  a  dialysis  membrane  (3500  cut-off),
thereby precluding  direct  interactions between cal-
protectin and the EL-4  cells. To pre-equilibrate zinc
concentrations before the addition of the cells, zinc-
deprived medium with or without calprotectin was
added in both chambers and allowed to stand at 4°C
for  3  days  to  equilibrate  zinc  concentrations.  As
shown in Figure 2, pretreatment of inner and outer
chambers  with  calprotectin  resulted  in  the  inhibi-
tion  of  MTT  reduction  of  EL-4  cells  in  the  both
chambers.  On  the  contrary,  when  only  the  outer
chambers were pretreated, the inhibition was again
observed not only in the outer chambers, but also in
the  inner  chambers,  showing  that  direct  contact
between  calprotectin  and  the  target  cells  was  not
necessary  for  induction  of  cell  death.  It  was  con-
firmed that calprotectin was  not  permeable  to  the
opposite chambers: when only the outer chambers
were pretreated with calprotectin as already descri-
bed, the subunit  proteins in  the supernatants from
the  inner  chambers  were  not  detected by  sodium
dodecyl  sulfate-polyacrylamide  gel  electrophoresis
with  silver  staining,  while  the  proteins  in  0.64mM
calprotectin  solution,  which  was  the  minimal  con-
centration for apoptosis induction in divalent-cation-
depleted medium, were clearly detectable (data not
shown).
Apoptosis-inducing effects of zinc chelators
To obtain further evidence that exclusion of extrac-
ellular zinc induces cell death, we next studied the
toxicity  of  zinc  chelators. As  shown  in  Figure  3a,
DTPA  (which  is  a  cell-membrane-impermeable
chelator)  causes  almost  complete  loss  of  MTT
S. Yui et al.
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FIG. 2. Test  of the requirement for direct contact between
rhMRP8/rhMRP14 and EL-4 cells to exert a cytotoxic effect.
Divalent-cation-depleted medium without or  with rhMRP8/
rhMRP14  complex  was  added  to  the  inner  and  outer
chambers of a double-chamber culture system, in which the
two chambers were separated by dialysis membrane (3500
cut-off) as described in Materials and methods. After being
stored at 4°C for 3 days, EL-4 cells were added to the inner
and outer chambers  as  indicated. After  culturing for  48h,
MTT-reducing  activity  of  EL-4  cells  in  the  inner  chamber
(white  bars)  and  the  outer  chamber  (black  bars)  were
measured. Bars  represent standard deviations of triplicate
estimations.
FIG. 3. EL-4 cell cytotoxicity of the cell-membrane-impermea-
ble Zn-chelator DTPA or the cell-membrane-permeable Zn-
chelator TPEN. The cells were cultured with (a) DTPA or (b)
TPEN in standard medium (closed symbols) or in divalent-
cation-depleted medium (open symbols). MTT assays were
preformed  after  culturing  for  (a)  48h  or  (b)  24h.  Bars
represent  standard  deviations of  triplicate  measurements.
When bars are not shown, they are smaller than the size of
the symbols.reduction in EL-4 cells at a concentration of 2.5mM
in  normal  medium  and  at  0.63mM  in  divalent-
cation-depleted medium. Like calprotectin, the cyto-
toxic activity of DTPA was more potent in divalent-
cation-depleted  medium  than  in  normal  medium.
The  membrane-permeable  chelator,  TPEN,  which
was  earlier  reported  to  have  apoptosis-inducing
activity,27–30 also  completely  suppressed  MTT
reduction  at  2.5mM  in  normal  medium  and  at
1.25mM  in  divalent-cation-depleted  medium  (Fig.
3b). Calprotectin and DTPA also induced a decrease
in  MTT-reducing  activity  of  human  cell  lines,
namely MOLT-4 leukemia cells and MCF-7 mammary
carcinoma cells,  in  quite  similar  concentration ran-
ges as the case of EL-4  cells,  respectively (data not
shown).
Figure 4 shows a kinetic study of changes in MTT
reduction of EL-4 cells cultured with calprotectin or
zinc  chelators.  Calprotectin  induced  a  decrease  of
about  half  in  the  MTT  reduction  after  27h  and  a
complete  loss  of  activity  at  48h  of  incubation.  A
membrane-impermeable  DTPA  suppressed  MTT
reduction with similar kinetics as calprotectin, while
membrane-permeable TPEN caused the suppression
with more rapid kinetics.
To ascertain whether DTPA induces apoptosis of
EL-4 cells, we analyzed the DNA profile of EL-4 cells
cultured  with  DTPA  since  DNA  fragmentation  is  a
hallmark  of  apoptosis.  As  shown  in  Figure  5,  in
addition to TPEN and cycloheximide used as positive
controls, recombinant human calprotectin and DTPA
both  induced  ladder-type  DNA  fragmentation,  and
consequently apoptosis.
Evidence of whether zinc chelation is essential in
the cytotoxic mechanism of calprotectin and DTPA
was sought by examining the effect of the addition of
zinc sulfate on the cytotoxic activities. As shown in
Figure 6, the cytotoxicity of DTPA and calprotectin as
well  as  TPEN  was  completely  abrogated  by  the
Zinc Exclusion and apoptosis by rhMRP8/14
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FIG.  4.  Time-courses  of  the  cell-death-inducing activity  of
rhMRP8/rhMRP14 complex, DTPA or TPEN. EL-4 cells were
cultured (s ) without, or (d ) with rhMRP8/rhMRP14 complex
(5mM), (j )  with DTPA  (10mM) or (©)  with TPEN  (5mM)  in
standard medium. MTT assays were performed at the time-
points indicated as described in Materials and methods. Bars
represent standard deviations of triplicate measurements.
FIG. 5. Agarose gel electrophoresis of DNA extracted from
EL-4 cells. Cells were cultured in standard medium without
or with rhMRP8/rhMRP14 complex (5mM) on DTPA (20mM)
for  24h,  or  with  TPEN  (10mM)  or  cycloheximide  (CHX)
(200mg/ml) for 6h. DNA was extracted and electrophoresed
as described in Materials and methods.
FIG.  6.  Inhibitory  effect  of  ZnSO4 on  apoptosis-inducing
activity of rhMRP8/rhMRP14 complex, DTPA, or TPEN. EL-4
cells were cultured in divalent-cation-depleted medium (s )
without,  or  (d )  with  rhMRP8/rhMRP14  complex  (2.5mM),
with (j ) DTPA (2.5mM) or (©) with TPEN (2.5mM) for 48h in
the absence or presence of the indicated concentrations of
ZnSO4.presence of zinc sulfate, suggesting that zinc chela-
tion  is  truly  implicated  in  apoptosis  induction  by
DTPA and calprotectin.
Discussion
In the present report we have examined the apopto-
sis-inducing activities of the calprotectin heterodimer
and  its  constituent  subunits  using  recombinant
human  proteins. An  equimolar  mixture  of  rhMRP8
and  rhMRP14  was  found  to  have  higher  specific
activity  than  either  subunit  alone.  The  effective
concentrations  of  rhMRP8/rhMRP14  activities  are
similar  to  those previously  reported  for  rat  calpro-
tectin.5 Therefore,  it  is  concluded  that  apoptosis-
inducing activity is not unique to rat calprotectin.
There are  several  observations supporting  a spe-
cific  mechanism  for  the  induction  of  apoptosis  by
calprotectin  that  involves  the  exclusion  of  extrac-
ellular  zinc. First, the cell-death-inducing activity of
rhMRP8/rhMRP14  (Fig.  6),  as  well  as  rat  calpro-
tectin,4–6 was  completely  inhibited  by  the  co-pres-
ence of zinc. Second, corresponding dose–response
curves were shifted to lower concentration ranges in
divalent-cation-depleted  medium  (Fig.  1).6 Third,
direct  physical  contact  between  calprotectin  and
tumor  cells  was not  required  to exert cytotoxicity.
Finally,  the  membrane-impermeable  zinc  chelator
DTPA decreased the  MTT-reducing  activity  of  EL–4
cells in a time-course similar to that of calprotectin,
whereas  membrane-permeable  zinc  chelator  TPEN
exerted cytotoxicity more rapidly. It was previously
reported  that  rhMRP8  and  rhMRP14  form  a  non-
covalently  associated  heterodimeric  complex  with
high preference over homodimers.24,31 The mixture
of MRP8 and MRP14 has higher specific activity than
either protein individually, and these proteins appear
to acquire higher zinc binding activity in the hetero-
dimeric  state. This  hypothesis  is  supported  by  the
X-ray crystal structure of Zn2+-bound S100A732and by
molecular  modeling  of  the  Zn2+-binding  sites  in
S100A6 and S100A2.33,34
The  results  presented  herein  suggest  that  direct
interaction is not required for the cytotoxic activity
exerted  by  calprotectin  on  target  cells.  However,
human leukemia cell lines22,35 and endothelial cells23
reportedly have binding sites for MRP8 and MRP14,
suggesting that some cell types have receptor(s) for
calprotectin. It is conceivable that membrane-bound
calprotectin is more effective in inducing apoptosis
than the freely soluble protein. One plausible explana-
tion  for  this  would  be  the  effective  localization of
calprotectin  to  cells  requiring  its  Zn-chelating
activity.
Antifungal  activity was reported to be  an extrac-
ellular function of calprotectin.18–21 Sohnle and co-
workers reported that calprotectin exerted a candida-
static effect by eliminating zinc in a medium that is
essential for Candida growth.26 Recent studies of the
antimicrobial activities of calprotectin using rhMRP8
and rhMRP14 examined Cys® Ser mutations, which
avoid  unwanted  formation  of  disulfides.21 These
workers found that neither MRP8 nor MRP14 showed
antimicrobial  activity  by  itself,  whereas  equimolar
concentrations of the two proteins potently inhibited
growth. Our studies of the apoptosis-inducing activ-
ities of recombinant wild-type proteins revealed that
MRP14 and MRP8 alone were able to cause target cell
death, although  their specific  activities were  lower
than that of the mixture. This discrepancy prompted
us  to  examine  the  suppression  of  the  growth  of
Candida  albicans by  the  wild-type  proteins.  Inter-
estingly,  we  found  that  the  isolated  rhMRP14  and
rhMRP8  (as  well  as  the  mixture)  exhibited  dose–
response  curves  quite  similar  to  those  of  their
cytotoxicity against EL-4 cells (unpublished observa-
tion),  including  the  enhancement  of  activity  in
divalent-cation-depleted media. The  apparent  differ-
ence  between  wild-type  and  mutated  proteins  is
surprising. The most probable explanation is that the
single cysteine residues in MRP14 and MRP8 play key
roles in the binding of Zn2+ ions. Substitution of these
residues  by  serine  is  anticipated  to  significantly
reduce Zn2+ affinity, although a corresponding effect
on  the  MRP14/MRP8  heterodimer would  be  antici-
pated. Clearly, further studies are required to establish
the cause of these apparent discrepancies.
Recently,  evidence  has  been  accumulating  that
implicates zinc deficiency in induction of apoptosis.
Zinc ions are observed to inhibit  apoptotic nuclea-
ses36 and  caspase  activation,37 and  chelation  of
intracellular  zinc  from  cells  induces  apoptosis.27–30
Martin et al. reported that human cell lines, Raji and
HL-60,  undergo apoptosis in  zinc-deficient media.38
However, the effect of extracellular zinc exclusion on
induction of apoptosis has not been fully elucidated.
To our knowledge, calprotectin is the first example
that  an  endogenous  factor  present  in  body  fluids
induces apoptosis by zinc exclusion from target cells.
Future  studies  will  examine  how  extracellular  zinc
chelation by calprotectin or DTPA affects intracellular
zinc concentration.
An intense increase in calprotectin concentration
has  been  observed  in  body  fluids  at  local  sites  of
inflammation,17 with  an  extremely  high amount  of
calprotectin (1–20mg/ml, i.e. 45–900mM as a hetero-
dimeric complex) in abscess fluids.16On the contrary,
zinc  concentrations  in  serum  of  healthy  human
subjects is about 15mM on average,39 and more than
one-half of serum zinc binds with albumin or amino
acids and is thought to be exchangeable with other
ligands.40 In areas where blood flow is limited in the
inflammatory sites, zinc deficiency may be induced
locally by calprotectin and may lead to apoptosis. This
high abundance of calprotectin might be injurious to
the cells in inflamed tissues if there is an insufficient
S. Yui et al.
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in  local  inflammatory  sites  such  as  abscesses,  in
which neutrophils extensively accumulate, may sur-
pass the inhibitory effect of zinc or other inhibitory
metals.6 This is supported by the observation repor-
ted  by  Sohnle  et  al. that the  supernatant fluids  of
abscess  showed  antifungal  activity  and  that  the
activity was  completely  reversed by  an addition of
zinc.41The findings in the present paper may help to
make a remedy for inflammation. For instance, the
possibility  can  be  raised that zinc supplement  may
suppress  tissue  destruction  in  local  inflammatory
sites, although in vivo activity of calprotectin awaits
further  research.  Also,  the  mechanism  underlying
apoptosis induction by calprotectin may be related to
the pathology of zinc deficiency.
The apoptosis-inducing activity of calprotectin by
zinc  chelation  might  also  function  in  intracellular
environments. Calprotectin is expressed abundantly
in the cytosol of neutrophils on differentiation of the
cell  lineage,  and  the  concentration  of  cytosolic
calprotectin  in  neutrophils  has  been  estimated  at
3 mM.12 Future  research  must  examine  whether
calprotectin is an endogenous factor of neutrophils
that contributes to, or perhaps even determines, the
brief life span of this cell type.
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